Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Gastrointestinal Tract”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02486198
What this trial is testing

Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal Cancer

Who this might be right for
Neurotoxicity
Tianjin Medical University Cancer Institute and Hospital 145
Testing effectiveness (Phase 2)Looking for participantsNCT06708663
What this trial is testing

HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours

Who this might be right for
Biliary Tract CancerMelanoma
Hangzhou Hanx Biopharmaceuticals, Ltd. 124
Not applicableStudy completedNCT02573974
What this trial is testing

Skeletal Muscle Energy Metabolism in Undernourished Patients With Gastrointestinal Cancer

Who this might be right for
UndernutritionGastrointestinal Cancer
University Hospital, Tours 51
Not applicableLooking for participantsNCT03452774
What this trial is testing

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Who this might be right for
Cancer, MetastaticCancerCancer of Pancreas+40 more
Massive Bio, Inc. 50,000
Early research (Phase 1)Study completedNCT02045368
What this trial is testing

Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R

Who this might be right for
Breast CancerBrain CancerGastrointestinal Cancers+5 more
IGF Oncology, LLC 92
Early research (Phase 1)Looking for participantsNCT04999761
What this trial is testing

AB122 Platform Study

Who this might be right for
Advanced or Metastatic Solid TumorPancreatic Ductal AdenocarcinomaColorectal Cancer+6 more
Taiho Pharmaceutical Co., Ltd. 917
Not applicableLooking for participantsNCT07462247
What this trial is testing

Establishment of Image Database for Early Upper Gastrointestinal Cancer, Precancerous Lesions, and Precancerous Conditions

Who this might be right for
Upper Gastrointestinal CancerUpper Gastrointestinal Precancerous LesionsUpper Gastrointestinal Precancerous Conditions
Changhai Hospital 500
Very early researchEnrolling By InvitationNCT07023848
What this trial is testing

PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors

Who this might be right for
Breast CancerGastric Cancer (GC)Urothelial Carcinoma (UC)
Affiliated Hospital of Jiangnan University 10
Not applicableStudy completedNCT07272538
What this trial is testing

Predicting Chemotherapy Toxicity Using FRAIL and FIND in Older Adults With Gastrointestinal Cancers

Who this might be right for
Gastrointestinal CancersFrailty at Older AdultsChemotherapy
Ankara Etlik City Hospital 84
Testing effectiveness (Phase 2)Ended earlyNCT03480152
What this trial is testing

Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer

Who this might be right for
MelanomaColon CancerGastrointestinal Cancer+2 more
National Cancer Institute (NCI) 5
Early research (Phase 1)Looking for participantsNCT05274048
What this trial is testing

Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients

Who this might be right for
Gastric CancerGastrointestinal CancerHER2 Gene Mutation
Fox Chase Cancer Center 18
Early research (Phase 1)Ended earlyNCT02268825
What this trial is testing

Phase I Study MK-3475 With Chemotherapy in Patients With Advanced GI Cancers

Who this might be right for
Advanced GI Cancer
University of Utah 39
Not applicableStudy completedNCT04602026
What this trial is testing

The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer

Who this might be right for
Adult Liver CarcinomaGastric CarcinomaMalignant Solid Neoplasm+1 more
Ohio State University Comprehensive Cancer Center 66
Early research (Phase 1)Study completedNCT02129933
What this trial is testing

VEGF-targeted Fluorescence Near-Infrared (NIR) Endoscopy in (Pre)Malignant Esophageal Lesions

Who this might be right for
Esophageal CancerDysplasia
University Medical Center Groningen 14
Not applicableNot Yet RecruitingNCT07490106
What this trial is testing

Benefits of Early Collaboration Between Oncologists and Palliative Care Physicians in Cases of Unplanned Hospitalization for Patients With Metastatic Cancer

Who this might be right for
CancerSarcoma MetastaticGynaecologic Cancer+3 more
Centre Oscar Lambret 493
Not applicableUnknownNCT06278064
What this trial is testing

Exosome-based Liquid Biopsies for Upper Gastrointestinal Cancers Diagnosis

Who this might be right for
Gastric CancerEsophagus Cancer
Beijing Friendship Hospital 562
Not applicableLooking for participantsNCT07524114
What this trial is testing

Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)

Who this might be right for
Breast CancerLung CancerMelanoma+7 more
University Health Network, Toronto 7,000
Testing effectiveness (Phase 2)Study completedNCT00354887
What this trial is testing

Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of Vater

Who this might be right for
Gastrointestinal Cancer
M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Study completedNCT01493206
What this trial is testing

A Prospective Single Arm Study of Intraoperative Radiotherapy for Locally Advanced or Recurrent Rectal Cancer

Who this might be right for
Malignant Rectal NeoplasmRecurrent Tumor
Peter MacCallum Cancer Centre, Australia 32
Not applicableStudy completedNCT04484636
What this trial is testing

PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)

Who this might be right for
Hepatocellular CancerCholangiocarcinomaGallbladder Cancer+3 more
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 400
Next Page